153 related articles for article (PubMed ID: 20302881)
1. Hyperglycemia attenuates acute permeability response to advanced glycation end products in retinal microvasculature.
Warboys CM; Fraser PA
Microvasc Res; 2010 Jul; 80(1):174-6. PubMed ID: 20302881
[TBL] [Abstract][Full Text] [Related]
2. Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation.
Warboys CM; Toh HB; Fraser PA
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1319-28. PubMed ID: 18997095
[TBL] [Abstract][Full Text] [Related]
3. MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline.
Chen YD; Xu X; Xia X; Wu H; Liu K; Zheng Z; Zhu D
Curr Eye Res; 2008 Nov; 33(11):977-83. PubMed ID: 19085380
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
Gardiner TA; Anderson HR; Stitt AW
J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
[TBL] [Abstract][Full Text] [Related]
6. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
7. Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954.
Catanzaro O; Labal E; Andornino A; Capponi JA; Di Martino I; Sirois P
Peptides; 2012 Apr; 34(2):349-52. PubMed ID: 22369720
[TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end product expression in experimental diabetic retinopathy.
Wang Y; Vom Hagen F; Pfister F; Bierhaus A; Feng Y; Gans R; Hammes HP
Ann N Y Acad Sci; 2008 Apr; 1126():42-5. PubMed ID: 18448794
[TBL] [Abstract][Full Text] [Related]
9. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain.
Scalia R; Gong Y; Berzins B; Zhao LJ; Sharma K
Diabetes; 2007 Jul; 56(7):1842-9. PubMed ID: 17446533
[TBL] [Abstract][Full Text] [Related]
11. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.
Kowluru RA
Life Sci; 2005 Jan; 76(9):1051-60. PubMed ID: 15607333
[TBL] [Abstract][Full Text] [Related]
12. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
Lawson SR; Gabra BH; Nantel F; Battistini B; Sirois P
Eur J Pharmacol; 2005 May; 514(1):69-78. PubMed ID: 15878326
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
14. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
Sohn E; Kim J; Kim CS; Lee YM; Kim JS
Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
Sheikpranbabu S; Haribalaganesh R; Lee KJ; Gurunathan S
Biochimie; 2010 Aug; 92(8):1040-51. PubMed ID: 20470857
[TBL] [Abstract][Full Text] [Related]
16. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
17. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
18. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina.
Hammes HP; Weiss A; Hess S; Araki N; Horiuchi S; Brownlee M; Preissner KT
Lab Invest; 1996 Sep; 75(3):325-38. PubMed ID: 8804356
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Min BH; Kim KW
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
[TBL] [Abstract][Full Text] [Related]
20. The RAGE axis in early diabetic retinopathy.
Barile GR; Pachydaki SI; Tari SR; Lee SE; Donmoyer CM; Ma W; Rong LL; Buciarelli LG; Wendt T; Hörig H; Hudson BI; Qu W; Weinberg AD; Yan SF; Schmidt AM
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2916-24. PubMed ID: 16043866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
